HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harald Stein Selected Research

22-1-1 antigen

5/2005Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harald Stein Research Topics

Disease

46Neoplasms (Cancer)
09/2018 - 01/2002
29Hodgkin Disease (Hodgkin's Disease)
06/2021 - 01/2002
23Lymphoma (Lymphomas)
04/2014 - 01/2002
19B-Cell Lymphoma (Lymphoma, B Cell)
11/2019 - 01/2002
9Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2021 - 08/2002
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2020 - 07/2003
6Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2017 - 11/2004
6Colorectal Neoplasms (Colorectal Cancer)
11/2007 - 06/2002
5Carcinogenesis
01/2015 - 08/2002
4Burkitt Lymphoma (Burkitt's Lymphoma)
11/2019 - 06/2006
4Pathologic Complete Response
01/2015 - 03/2005
4Multiple Myeloma
06/2011 - 07/2002
3Disease Progression
12/2021 - 07/2009
3T-Cell Lymphoma (Lymphoma, T Cell)
12/2021 - 07/2003
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 08/2007
3Carcinoma (Carcinomatosis)
01/2009 - 04/2004
3Breast Neoplasms (Breast Cancer)
06/2007 - 10/2002
3Inflammation (Inflammations)
02/2006 - 07/2002
3Intraocular Lymphoma
11/2005 - 10/2003
2Genetic Translocation (Chromosomal Translocation)
04/2014 - 07/2011
2Necrosis
05/2012 - 06/2003
2Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2008 - 01/2005
2Hairy Cell Leukemia
01/2008 - 08/2007
2Acquired Immunodeficiency Syndrome (AIDS)
08/2007 - 08/2005
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2006 - 05/2005
2Uveitis
09/2005 - 10/2003
2Neoplasm Metastasis (Metastasis)
03/2005 - 07/2002
2Hyperplasia
11/2004 - 05/2003
1Fibrosis (Cirrhosis)
05/2016
1Osteosclerosis
05/2016
1Primary Myelofibrosis (Myelosclerosis)
05/2016
1Leukemia
02/2013
1Colonic Neoplasms (Colon Cancer)
07/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2010
1Langerhans Cell Sarcoma
09/2010
1Lymphadenopathy
04/2010

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2002
10Immunoglobulins (Immunoglobulin)IBA
11/2012 - 01/2002
9Doxorubicin (Adriamycin)FDA LinkGeneric
06/2021 - 11/2004
9AntigensIBA
11/2007 - 01/2002
7Transcription Factors (Transcription Factor)IBA
02/2013 - 01/2004
6Vincristine (Oncovin)FDA LinkGeneric
06/2021 - 08/2010
6Prednisone (Sone)FDA LinkGeneric
06/2021 - 08/2010
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2021 - 08/2010
6Biological ProductsIBA
04/2014 - 01/2002
5Bleomycin (Blenoxane)FDA LinkGeneric
06/2021 - 03/2012
5ParaffinIBA
08/2017 - 10/2002
5DNA (Deoxyribonucleic Acid)IBA
09/2015 - 10/2005
5Monoclonal AntibodiesIBA
02/2014 - 05/2005
5NF-kappa B (NF-kB)IBA
05/2008 - 08/2002
4Procarbazine (Matulane)FDA Link
06/2021 - 08/2010
4Etoposide (VP 16)FDA LinkGeneric
06/2021 - 08/2010
4RNA (Ribonucleic Acid)IBA
07/2011 - 10/2002
4Chemokine ReceptorsIBA
11/2009 - 02/2002
4AntibodiesIBA
06/2009 - 02/2004
4GABA-A Receptors (GABA(A) Receptor)IBA
08/2005 - 10/2002
4LigandsIBA
11/2004 - 02/2002
3Formaldehyde (Formol)FDA Link
08/2017 - 01/2008
3Rituximab (Mabthera)FDA Link
01/2017 - 03/2013
3Dacarbazine (DIC)FDA LinkGeneric
04/2015 - 08/2010
2Pyridinolcarbamate (P23)IBA
10/2021 - 04/2009
2carboxyl radical (COO-)IBA
09/2018 - 08/2017
2Therapeutic UsesIBA
05/2016 - 06/2009
2Vinblastine (Vinblastine Sulfate)FDA Link
04/2015 - 03/2012
2Histones (Histone)IBA
02/2013 - 06/2011
2Biomarkers (Surrogate Marker)IBA
07/2009 - 08/2007
2Messenger RNA (mRNA)IBA
01/2009 - 01/2009
2Neoplasm Antigens (Tumor Antigens)IBA
07/2008 - 11/2007
2TNF Receptor-Associated Factor 1IBA
08/2007 - 06/2003
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2005 - 11/2004
2bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
08/2005 - 06/2002
2gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA
05/2005 - 07/2002
2Telomerase (Telomerase Reverse Transcriptase)IBA
05/2003 - 10/2002
2ChemokinesIBA
07/2002 - 02/2002
1Anaplastic Lymphoma KinaseIBA
10/2021
1Complement System Proteins (Complement)IBA
01/2019
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
08/2017
1Janus Kinase InhibitorsIBA
05/2016
1CollagenIBA
05/2016
1Reticulin (Reticular Fiber)IBA
05/2016
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2015
1Interleukin-1 (Interleukin 1)IBA
01/2015
1Protein Isoforms (Isoforms)IBA
01/2015
1Ki-1 AntigenIBA
02/2014
1Lysine (L-Lysine)FDA Link
02/2013
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2012
1LectinsIBA
02/2012
1Galactose (Galactopyranose)FDA LinkGeneric
02/2012
1ChromatinIBA
06/2011
1Macrophage Colony-Stimulating FactorIBA
05/2010
1Co-Repressor ProteinsIBA
05/2010
1Interferon-gamma (Interferon, gamma)IBA
04/2010

Therapy/Procedure

18Therapeutics
12/2021 - 09/2002
11Drug Therapy (Chemotherapy)
12/2017 - 09/2002
7Radiotherapy
05/2012 - 09/2002
3Stem Cell Transplantation
01/2020 - 02/2006
2Immunotherapy
06/2007 - 05/2005
2Vitrectomy
09/2005 - 10/2003
1Salvage Therapy
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
12/2017